Viewing Study NCT06530706


Ignite Creation Date: 2025-12-26 @ 1:18 PM
Ignite Modification Date: 2025-12-31 @ 7:05 PM
Study NCT ID: NCT06530706
Status: COMPLETED
Last Update Posted: 2025-09-16
First Post: 2024-07-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Effect of Esketamine on Anxiety State in Patients Undergoing Abdominal Tumor Surgery
Sponsor: Zhejiang Cancer Hospital
Organization:

Study Overview

Official Title: Effect of Esketamine on Anxiety State in Patients Undergoing Abdominal Tumor Surgery
Status: COMPLETED
Status Verified Date: 2025-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: To evaluate whether esketamine can relieve anxiety in patients undergoing abdominal tumor surgery.
Detailed Description: Hamilton anxiety Scale was used to screen patients with anxiety. Only patients with score ≥ 8 were enrolled. These patients were randomly assigned to the experimental group and control group.

All patients enrolled were evaluated with Hamilton anxiety Scale, PHQ-8 scale, QoR-15 Scale and Athens Insomnia Scale. After induction, sevoflurane and remifentanil were used to maintain anesthesia. The experimental group had esketamine while the control group had normal saline. Athens Insomnia Scale was used to assess the sleep status 1, 2, 3 days after surgery and 1 month after surgery. Hamilton anxiety Scale was used to evaluate the anxiety state of the patients 3 days after surgery and 1 month after surgery. PHQ-8 scale, QoR-15 Scale were collected 3 days after surgery and 1 month after surgery.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: